Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Clin Transl Oncol ; 2024 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-38722534

RESUMO

PURPOSE: We evaluated the prevalence of homologous recombination deficiencies (HRD) to determine the efficacy of different techniques and clinical characteristics of patients. METHODS: This retrospective study included patients with metastatic prostate cancer who underwent molecular testing at our hospital between 2016 and 2022. We used tumor tissue, ctDNA, and lymphocytes for somatic or germline testing. We analyzed the clinical characteristics and survival outcomes. RESULTS: 144 patients were tested (113 somatic, 21 germline, and 10 both). Technical issues prevented the analysis of 23 prostatic samples (18.7%). 12 (8.3%) patients had HRD. BRCA2 was the most frequent mutation (66.7%). Patients with HRD were younger (57.5 years). Patients with BRCA mutations had poorer survival (31.9 vs 56.3 months, p = 0.048). CONCLUSION: In our institution, 8.3% of the patients had HRD. Tumor tissue analysis failed in 18.7% of tests. ctDNA analysis is an alternative detection method. BRCA mutations are correlated with poor prognosis.

2.
Nefrologia (Engl Ed) ; 43 Suppl 2: 91-95, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-38278716

RESUMO

Fabry disease or also called Anderson-Fabry disease (FD) is a rare disease caused by pathogenic variants in the GLA gene, located on the X chromosome. This gene is involved in the metabolism of glycosphingolipids and its pathogenic variants cause a deficit or absence of α-galactosidase A causing the deposition of globotriaosylceramide throughout the body. Females have a variable phenotypic expression and a better prognosis than males. This is due to the X chromosome inactivation phenomenon. We present a clinical case of Fabry disease in a female with predominantly renal involvement and demonstrate how the X chromosome inactivation phenomenon is tissue dependent, showing preferential inactivation of the mutated allele at the renal level.


Assuntos
Doença de Fabry , Masculino , Feminino , Humanos , Doença de Fabry/genética , Doença de Fabry/patologia , Inativação do Cromossomo X , alfa-Galactosidase/genética , alfa-Galactosidase/metabolismo , Rim/patologia , Fenótipo
3.
Am J Kidney Dis ; 78(4): 560-570.e1, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-33838161

RESUMO

RATIONALE & OBJECTIVE: Alport syndrome is a common genetic kidney disease accounting for approximately 2% of patients receiving kidney replacement therapy (KRT). It is caused by pathogenic variants in the gene COL4A3, COL4A4, or COL4A5. The aim of this study was to evaluate the clinical and genetic spectrum of patients with autosomal dominant Alport syndrome (ADAS). STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 82 families (252 patients) with ADAS were studied. Clinical, genetic, laboratory, and pathology data were collected. OBSERVATIONS: A pathogenic DNA variant in COL4A3 was identified in 107 patients (35 families), whereas 133 harbored a pathogenic variant in COL4A4 (43 families). Digenic/complex inheritance was observed in 12 patients. Overall, the median kidney survival was 67 (95% CI, 58-73) years, without significant differences across sex (P=0.8), causative genes (P=0.6), or type of variant (P=0.9). Microhematuria was the most common kidney manifestation (92.1%), and extrarenal features were rare. Findings on kidney biopsies ranged from normal to focal segmental glomerulosclerosis. The slope of estimated glomerular filtration rate change was-1.46 (-1.66 to-1.26) mL/min/1.73m2 per year for the overall group, with no significant differences between ADAS genes (P=0.2). LIMITATIONS: The relatively small size of this series from a single country, potentially limiting generalizability. CONCLUSIONS: Patients with ADAS have a wide spectrum of clinical presentations, ranging from asymptomatic to kidney failure, a pattern not clearly related to the causative gene or type of variant. The diversity of ADAS phenotypes contributes to its underdiagnosis in clinical practice.


Assuntos
Autoantígenos/genética , Colágeno Tipo IV/genética , Testes Genéticos/métodos , Variação Genética/genética , Nefrite Hereditária/diagnóstico , Nefrite Hereditária/genética , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nefrite Hereditária/epidemiologia , Insuficiência Renal/diagnóstico , Insuficiência Renal/epidemiologia , Insuficiência Renal/genética , Estudos Retrospectivos , Adulto Jovem
4.
Rev. esp. patol ; 53(3): 197-199, jul.-sept. 2020. ilus
Artigo em Espanhol | IBECS | ID: ibc-194272

RESUMO

Múltiples son las variantes histológicas del carcinoma urotelial, la mayoría en carcinomas de alto grado, localmente avanzados. Una de las más infrecuentes es la formada por células epiteliales con contenido de lípidos y aspecto de tejido adiposo. De esta variante solo se han publicado 43 casos en vejiga, 2 en pelvis renal y un caso en uréter. Presentamos un tercer caso de pelvis renal. La paciente sigue viva y libre de enfermedad a los 103 meses de la nefroureterectomía. Se revisan los criterios diagnósticos y el impacto pronóstico


There are many variants of urothelial carcinoma. One of the most infrequent is formed by cells with a lipid content and an adipose tissue appearance. Only 43 cases have been reported in the bladder, 2 in the renal pelvis and 1 case in the ureter. We present a third case in the renal pelvis; the patient is alive and free of disease 103 months post diagnosis


Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Carcinoma de Células de Transição/classificação , Carcinoma de Células de Transição/diagnóstico , Neoplasias Renais/diagnóstico , Pelve Renal , Carcinoma de Células de Transição/cirurgia , Neoplasias Renais/cirurgia , Nefroureterectomia
5.
Rev Esp Patol ; 53(3): 197-199, 2020.
Artigo em Espanhol | MEDLINE | ID: mdl-32650972

RESUMO

There are many variants of urothelial carcinoma. One of the most infrequent is formed by cells with a lipid content and an adipose tissue appearance. Only 43 cases have been reported in the bladder, 2 in the renal pelvis and 1 case in the ureter. We present a third case in the renal pelvis; the patient is alive and free of disease 103 months post diagnosis.


Assuntos
Neoplasias Renais/patologia , Pelve Renal/patologia , Neoplasias Lipomatosas/patologia , Adipócitos/patologia , Feminino , Humanos , Neoplasias Renais/cirurgia , Pelve Renal/cirurgia , Pessoa de Meia-Idade , Gradação de Tumores , Neoplasias Lipomatosas/cirurgia
6.
Nefrología (Madrid) ; 39(2): 198-201, mar.-abr. 2019. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-181328

RESUMO

La gammapatía monoclonal de significado renal incluye todas las enfermedades renales causadas por una inmunoglobulina monoclonal secretada por un clon de célula B no maligno. Por definición, los pacientes con gammapatía monoclonal de significado renal no cumplen criterios de mieloma múltiple y la alteración hematológica es generalmente considerada gammapatía monoclonal de significado incierto. No obstante, la dolencia que pueden causar a nivel renal puede ser importante, requiriendo un tratamiento específico. El espectro de la gammapatía monoclonal de significado renal es amplio, incluyendo una entidad reciente como la nefropatía C3. El desarrollo de una nefropatía C3 en el contexto de una gammapatía monoclonal de significado renal tras el trasplante renal no es frecuente y hasta el momento ha sido poco descrita. A continuación presentamos 3 casos de nefropatía C3 asociados a una gammapatía monoclonal de aparición de novo tras el trasplante renal


Monoclonal gammopathy of renal significance includes all renal disorders caused by a monoclonal immunoglobulin secreted by a non-malignant B-cell clone. Patients with MGRS do not, by definition, meet criteria for multiple myeloma, with haematological disorders generally considered to be monoclonal gammopathy of undetermined significance. Nevertheless, the renal involvement can be serious and require specific treatment. Monoclonal gammopathy of renal significance is associated with a wide spectrum of disorders, including the recently discovered C3 glomerulopathy. Development of C3 glomerulopathy in the context of monoclonal gammopathy of renal significance after kidney transplantation is uncommon and very few cases have been published to date. We report on three cases of C3 glomerulopathy in the context of de novo monoclonal gammopathy after kidney transplantation


Assuntos
Humanos , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Paraproteinemias/etiologia , Nefropatias/complicações , Insuficiência Renal Crônica/genética , Transplante de Rim/métodos , Glomerulonefrite/diagnóstico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Terapia de Imunossupressão/métodos , Rituximab/administração & dosagem , Biópsia , Diagnóstico Precoce
7.
Nefrologia (Engl Ed) ; 39(2): 198-201, 2019.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29914760

RESUMO

Monoclonal gammopathy of renal significance includes all renal disorders caused by a monoclonal immunoglobulin secreted by a non-malignant B-cell clone. Patients with MGRS do not, by definition, meet criteria for multiple myeloma, with haematological disorders generally considered to be monoclonal gammopathy of undetermined significance. Nevertheless, the renal involvement can be serious and require specific treatment. Monoclonal gammopathy of renal significance is associated with a wide spectrum of disorders, including the recently discovered C3 glomerulopathy. Development of C3 glomerulopathy in the context of monoclonal gammopathy of renal significance after kidney transplantation is uncommon and very few cases have been published to date. We report on three cases of C3 glomerulopathy in the context of de novo monoclonal gammopathy after kidney transplantation.


Assuntos
Complemento C3 , Nefropatias/etiologia , Transplante de Rim/efeitos adversos , Paraproteinemias/complicações , Complicações Pós-Operatórias/etiologia , Idoso , Feminino , Glomerulonefrite/diagnóstico , Glomerulonefrite/tratamento farmacológico , Glomerulonefrite/etiologia , Humanos , Nefropatias/imunologia , Nefropatias/cirurgia , Masculino , Pessoa de Meia-Idade , Paraproteinemias/imunologia , Doenças Renais Policísticas/complicações , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/imunologia , Canais de Cátion TRPP/genética
9.
Rev. int. androl. (Internet) ; 15(4): 165-168, oct.-dic. 2017. ilus
Artigo em Espanhol | IBECS | ID: ibc-166863

RESUMO

La neoplasia testicular intratubular es una lesión premaligna testicular asociada a tumores germinales primarios gonadales y extragonadales. La prevalencia de neoplasia testicular intratubular en pacientes infértiles llega al 2% en diferentes estudios. Presentamos el caso de un paciente azoospérmico con diagnóstico incidental de neoplasia testicular intratubular bilateral en la biopsia testicular realizada durante la recuperación quirúrgica de espermatozoides. En pacientes infértiles, las técnicas de recuperación espermática deben incluir el estudio anatomopatológico de parénquima testicular para descartar enfermedad maligna asociada. Los pacientes con alteración de la espermatogénesis tienen mayor riesgo de presentar otras alteraciones del desarrollo gonadal (neoplasias, hipogonadismo, entre otros) en el contexto de un síndrome de disgenesia testicular (AU)


Testicular intraepithelial neoplasia is a premalignant lesion associated to gonadal and extragonadal germ cell tumors. Testicular intraepithelial neoplasia prevalence in infertile men has reached 2% in some studies. This report presents the case of an azoospermic man with an incidental diagnosis of bilateral testicular intraepithelial neoplasia after testicular sperm extraction. In infertile men, sperm retrieving techniques have to include histological analysis of testicular tissue, to discard any chance of malignant component. Patients with spermatogenesis alterations have an increased risk to present other disruptions in gonadal development (neoplasms, hypogonadism, among others) in the context of testicular dysgenesis syndrome (AU)


Assuntos
Humanos , Masculino , Adulto , Neoplasias Testiculares/complicações , Neoplasias Testiculares/diagnóstico , Neoplasias Testiculares/cirurgia , Infertilidade Masculina/complicações , Espermatogênese , Biópsia , Azoospermia/complicações , Azoospermia/diagnóstico , Imuno-Histoquímica/métodos , Fotomicrografia/métodos , Testículo/patologia
10.
Clin J Am Soc Nephrol ; 9(5): 897-904, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24578331

RESUMO

BACKGROUND AND OBJECTIVES: Several studies have suggested that activation of the complement system is a contributing pathogenic mechanism in IgA nephropathy (IgAN). C4d staining is an inexpensive and easy-to-perform method for the analysis of renal biopsies. This study aimed to assess the clinical and prognostic implications of C4d staining in IgAN. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This retrospective cohort study included 283 patients with IgAN in 11 hospitals in Spain who underwent a renal biopsy between 1979 and 2010. The primary predictor was mesangial C4d staining. Secondary predictors included demographic, clinical, and laboratory characteristics, and Oxford pathologic classification criteria. The primary end point was the cumulative percentage of patients who developed ESRD, defined as onset of chronic dialysis or renal transplantation. C4d was analyzed by immunohistochemical staining using a polyclonal antibody. Kaplan-Meier and Cox proportional hazards analyses were performed to evaluate the effect of C4d staining on renal survival. RESULTS: There were 109 patients (38.5%) and 174 patients (61.5%) who were classified as C4d positive and C4d negative, respectively. Renal survival at 20 years was 28% in C4d-positive patients versus 85% in C4d-negative patients (P<0.001). Independent risk factors associated with ESRD were as follows: proteinuria (hazard ratio [HR] per every 1 g/d increase. 1.16; 95% confidence interval [95% CI], 1.03 to 1.31; P=0.01), eGFR (HR per every 1 ml/min per 1.73 m(2) increase, 0.96; 95% CI, 0.94 to 0.97; P<0.001), T2 Oxford classification (tubular atrophy/interstitial fibrosis, >50%; HR, 4.42; 95% CI, 1.40 to 13.88; P=0.01), and C4d-positive staining (HR, 2.45; 95% CI, 1.30 to 4.64; P=0.01). CONCLUSIONS: C4d-positive staining is an independent risk factor for the development of ESRD in IgAN. This finding is consistent with the possibility that complement activation is involved in the pathogenesis of this disease.


Assuntos
Complemento C4b/análise , Doença Hepática Terminal/fisiopatologia , Glomerulonefrite por IGA/patologia , Glomerulonefrite por IGA/fisiopatologia , Rim/patologia , Células Mesangiais/química , Fragmentos de Peptídeos/análise , Adulto , Biópsia , Progressão da Doença , Doença Hepática Terminal/etiologia , Doença Hepática Terminal/metabolismo , Doença Hepática Terminal/patologia , Feminino , Taxa de Filtração Glomerular , Glomerulonefrite por IGA/complicações , Glomerulonefrite por IGA/metabolismo , Humanos , Hipertelorismo/complicações , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Rim/química , Masculino , Pessoa de Meia-Idade , Prognóstico , Proteinúria/etiologia , Estudos Retrospectivos , Fatores de Risco , Adulto Jovem
11.
Actas Fund. Puigvert ; 32(4): 143-148, dic. 2013. ilus
Artigo em Espanhol | IBECS | ID: ibc-119103

RESUMO

Los carcinomas renales familiares tienen como una de sus principales características la multifocalidad y la bilateralidad. En las formas esporádicas del cáncer renal: Los carcinomas renales papilares son mucho más frecuentemente múltiples/bilaterales que los carcinomas de células claras. Los carcinomas de células claras multifocales tienen un mayor riesgo de bilateralidad asincrónica. Los carcinomas cromófobos con células de tipo oncocitoma son con mayor frecuencia múltiples y multifocales


Diet affect oxalic lithiasis patients, increasing the risk factors for stone formation. Upon completion of the metabolic study should give some dietary guidelines based on scientific data. Few studies have analyzed completely the oxalate content in foods of the human diet. It must be emphasized abundant fluid intake, reducing salt and animal protein, maintaining proper calcium intake. In this paper, some tables about oxalate content in various foods are attached. Most rich in oxalate (chard, spinach, cauliflower, tea, cocoa, kiwis) must be restricted


Assuntos
Humanos , Angiomiolipoma/patologia , Neoplasias de Células Epitelioides Perivasculares/patologia , Biomarcadores Tumorais/análise , Células Clonais/patologia
12.
Actas Fund. Puigvert ; 32(4): 149-154, dic. 2013.
Artigo em Espanhol | IBECS | ID: ibc-119105

RESUMO

Los carcinomas renales familiares tienen como una de sus principales características la multifocalidad y la bilateralidad. En las formas esporádicas del cáncer renal: Los carcinomas renales papilares son mucho más frecuentemente múltiples/bilaterales que los carcinomas de células claras. Los carcinomas de células claras multifocales tienen un mayor riesgo de bilateralidad asincrónica. Los carcinomas cromófobos con células de tipo oncocitoma son con mayor frecuencia múltiples y multifocales (AU)


Diet affect oxalic lithiasis patients, increasing the risk factors for stone formation. Upon completion of the metabolic study should give some dietary guidelines based on scientific data. Few studies have analyzed completely the oxalate content in foods of the human diet. It must be emphasized abundant fluid intake, reducing salt and animal protein, maintaining proper calcium intake. In this paper, some tables about oxalate content in various foods are attached. Most rich in oxalate (chard, spinach, cauliflower, tea, cocoa, kiwis) must be restricted (AU)


Assuntos
Humanos , Neoplasias Renais/patologia , Carcinoma de Células Renais/patologia , Tamanho do Núcleo Celular , Estadiamento de Neoplasias , Neoplasias Primárias Múltiplas/patologia
13.
J Am Soc Nephrol ; 23(10): 1753-60, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22956820

RESUMO

The long-term outcome of patients with IgA nephropathy who present with normal renal function, microscopic hematuria, and minimal or no proteinuria is not well described. Here, we studied 141 Caucasian patients with biopsy-proven IgA nephropathy who had minor abnormalities at presentation and a median follow-up of 108 months. None of the patients received corticosteroids or immunosuppressants. We reviewed renal biopsies using the Oxford classification criteria. In this sample, 46 (32%) patients had mesangial proliferation, whereas endocapillary proliferation, focal glomerulosclerosis, and tubulointerstitial abnormalities were uncommon. Serum creatinine increases >50% and >100% were observed in five (3.5%) patients and one (0.7%) patient, respectively; no patients developed ESRD. After 10, 15, and 20 years, 96.7%, 91.9%, and 91.9% of patients maintained serum creatinine values less than a 50% increase, respectively. Using Cox proportional hazards regression, the presence of segmental glomerulosclerosis was the only factor that significantly associated with a >50% increase in serum creatinine. Clinical remission occurred in 53 (37.5%) patients after a median of 48 months. Proteinuria>0.5 and >1.0 g/24 h developed in 21 (14.9%) and 6 (4.2%) patients, respectively. Median proteinuria at the end of follow-up was 0.1 g/24 h, with 41 (29.1%) patients having no proteinuria. At presentation, 23 (16.3%) patients were hypertensive compared with 30 (21.3%) patients at the end of follow-up; 59 (41.8%) patients were treated with renin-angiotensin blockers because of hypertension or increasing proteinuria. In summary, the long-term prognosis for Caucasian patients with IgA nephropathy who present with minor urinary abnormalities and normal renal function is excellent.


Assuntos
Glomerulonefrite por IGA/patologia , Glomerulonefrite por IGA/fisiopatologia , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Creatinina/sangue , Feminino , Glomerulonefrite por IGA/complicações , Humanos , Rim/patologia , Falência Renal Crônica/etiologia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Prognóstico , Proteinúria/etiologia , Adulto Jovem
14.
J Cell Physiol ; 227(4): 1521-8, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21678404

RESUMO

Epithelial-to-mesenchymal transition (EMT) is an important pro-fibrotic event in which tubular epithelial cells are transformed into myofibroblasts. Nucleoside transporters (NT) are regulated by many factors and processes, some of which are involved in fibrosis, such as cytokines, inflammation, and proliferation. Equilibrative nucleoside transporter 1 (ENT1) has been proved to be the most widely expressed adenosine transporter. In that sense, ENT1 may be a key player in cell damage signaling. Here we analyze the role of human ENT1 (hENT1) in the EMT process in proximal tubular cells. Addition of the main inducer of EMT, the transforming growth factor-ß1, to HK-2 cells increased hENT1 mRNA and protein level expression. ENT1-mediated adenosine uptake was also enhanced. When cells were incubated with dipyridamole to evaluate the potential contribution of ENT1 to EMT by blocking its transport activity, EMT was induced. Moreover, the knock down of hENT1 with siRNA induced EMT and collagen production in HK-2 cells. Kidneys isolated from ENT1 knockout mice showed higher levels of interstitial collagen and α-SMA positive cells than wild-type mice. Our results point to a new potential role of hENT1 as a modulator of EMT in proximal tubular cells. In this sense, hENT1 could be involved in renal protection processes, and the loss or reduced expression of hENT1 would lead to an increased vulnerability of cells to the onset and/or progression of renal fibrosis.


Assuntos
Transição Epitelial-Mesenquimal/fisiologia , Transportador Equilibrativo 1 de Nucleosídeo/metabolismo , Túbulos Renais Proximais/metabolismo , Adenosina/metabolismo , Animais , Sequência de Bases , Linhagem Celular , Colágeno/biossíntese , Transição Epitelial-Mesenquimal/genética , Transportador Equilibrativo 1 de Nucleosídeo/antagonistas & inibidores , Transportador Equilibrativo 1 de Nucleosídeo/genética , Fibrose , Expressão Gênica/efeitos dos fármacos , Técnicas de Silenciamento de Genes , Humanos , Túbulos Renais Proximais/citologia , Túbulos Renais Proximais/efeitos dos fármacos , Camundongos , Camundongos Knockout , RNA Interferente Pequeno/genética , Transdução de Sinais/fisiologia , Fator de Crescimento Transformador beta1/farmacologia
15.
J Cell Physiol ; 227(5): 1980-7, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-21732369

RESUMO

Hypertrophy of human mesangial cells (HMC) is among the earliest characteristics in patients with diabetic nephropathy (DN). Recently, we observed the upregulation of parathyroid hormone (PTH)-related protein (PTHrP) in experimental DN, associated with renal hypertrophy. Herein, we first examined whether PTHrP was overexpressed in human DN, and next assessed the putative role of this protein on high glucose (HG)-induced HMC hypertrophy. As previously found in mice, kidneys from diabetic patients showed an increased tubular and glomerular immunostaining for PTHrP. In HMC, HG medium increased PTHrP protein expression associated with the development of hypertrophy as assessed by cell protein content. This effect was also induced by PTHrP(1-36). HG and PTHrP(1-36)-induced hypertrophy were associated with an increase in cyclin D1 and p27Kip1 protein expression, a decreased cyclin E expression, and the prevention of cyclin E/cdk2 complex activation. Both PTHrP neutralizing antiserum (α-PTHrP) and the PTH/PTHrP receptor antagonist (JB4250) were able to abolish HG induction of hypertrophy, the aforementioned changes in cell cycle proteins, and also TGF-ß1 up-regulation. Moreover, the capability of both HG and PTHrP(1-36) to induce HMC hypertrophy was abolished by α-TGFß1. These data show for the first time that PTHrP is upregulated in the kidney of patients with DN. Our findings also demonstrate that PTHrP acts as an important mediator of HG-induced HMC hypertrophy by modulating cell cycle regulatory proteins and TGF-ß1.


Assuntos
Nefropatias Diabéticas/metabolismo , Nefropatias Diabéticas/patologia , Rim/metabolismo , Rim/patologia , Células Mesangiais/metabolismo , Células Mesangiais/patologia , Proteína Relacionada ao Hormônio Paratireóideo/metabolismo , Animais , Proliferação de Células , Células Cultivadas , Ciclina D1/genética , Ciclina D1/metabolismo , Ciclina E/genética , Ciclina E/metabolismo , Quinase 2 Dependente de Ciclina/genética , Quinase 2 Dependente de Ciclina/metabolismo , Inibidor de Quinase Dependente de Ciclina p27/genética , Inibidor de Quinase Dependente de Ciclina p27/metabolismo , Feminino , Humanos , Hipertrofia/metabolismo , Hipertrofia/patologia , Rim/citologia , Masculino , Células Mesangiais/citologia , Camundongos , Pessoa de Meia-Idade , Proteína Relacionada ao Hormônio Paratireóideo/genética , Fator de Crescimento Transformador beta1/metabolismo
16.
Nephrol Dial Transplant ; 26(10): 3408-11, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21771756

RESUMO

Decreased renal function has been observed in diseases with intravascular haemolysis, including paroxysmal nocturnal haemoglobinuria (PNH). However, the mechanisms via which haemoglobin enhances renal damage in this pathology are not fully known. We report a case of acute renal failure associated to PNH and extensive haemosiderin deposits in tubular cells. Renal biopsy also revealed a strong immunostaining of CD163 (a haemoglobin scavenger receptor expressed in macrophages) and oxidative stress markers (NADPH-p22 phox and haeme oxigenase-1) in areas with deposits of iron. This fact provides evidence for a pathogenic role for free haemoglobin in tubulointerstitial renal injury in human PNH disease.


Assuntos
Injúria Renal Aguda/complicações , Biomarcadores/metabolismo , Hemoglobinúria Paroxística/diagnóstico , Hemoglobinúria Paroxística/etiologia , Hemossiderina/metabolismo , Túbulos Renais/fisiopatologia , Adulto , Antígenos CD/metabolismo , Antígenos de Diferenciação Mielomonocítica/metabolismo , Heme Oxigenase-1/metabolismo , Hemoglobinas/metabolismo , Humanos , Técnicas Imunoenzimáticas , Ferro/metabolismo , Macrófagos/metabolismo , Masculino , NADP/metabolismo , NADPH Oxidases/metabolismo , Receptores de Superfície Celular/metabolismo , Adulto Jovem
17.
Actas Fund. Puigvert ; 28(3): 117-122, jul. 2009.
Artigo em Espanhol | IBECS | ID: ibc-91674

RESUMO

La rápida evolución de los métodos diagnósticos por la imagen incorporan muy diversos aspectos de la biología, lo que obliga a intentar correlacionar los hallazgos con estas nuevas técnicas con aspectos morfobiológicos que previamente no estaban cosniderados en el diagnóstico anátomo-patológico. El uso de la espectrocopia es uno de los últimos métodos y es el propósito de esta breve reseña el correlacionar las variaciones metabólicas que pueden fundamentar las diferentes imágenes (AU)


No disponible


Assuntos
Humanos , Anatomia Regional , Diagnóstico por Imagem/métodos , Espectrometria de Massas/métodos
18.
Recent Results Cancer Res ; 175: 9-24, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17432551

RESUMO

The stem (basal) cells of prostate acini are considered the origin of prostate cancer. Between these cells and the final secretory cells, different intermediate or transit cells can be observed, and every one of them can evolve into malignant cells, explaining the biological variability of prostatic cancer. The exact changes between normal gland and prostatic intraepithelial neoplasia (PIN) are not yet known, but a post-inflammatory atrophy lesion is being studied in this respect. The PIN lesion is considered the pre-invasive change of prostatic cancer and its presence in needle biopsy is clinically used for follow-up of the patient. The progressive knowledge of the stromal invasion in prostate cancer (loss of some cell-cell adhesion molecules and expression of others) can be correlated with the Gleason grading system, and the molecular changes in the progression to androgen-independent carcinoma can be used as a prognostic marker in conjunction with the classical pathological markers.


Assuntos
Lesões Pré-Cancerosas/patologia , Próstata/patologia , Hiperplasia Prostática/patologia , Neoplasia Prostática Intraepitelial/patologia , Neoplasias da Próstata/patologia , Adenocarcinoma/patologia , Adenocarcinoma/secundário , Progressão da Doença , Humanos , Masculino , Invasividade Neoplásica/patologia
19.
Cancer Genet Cytogenet ; 173(2): 131-5, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17321328

RESUMO

We evaluated the performance of a multiprobe FISH (fluorescence in situ hybridization) assay for noninvasive detection of superficial urothelial carcinoma (UC) in the bladder, in comparison to urinary cytology. Voided urine samples from 74 patients with superficial UC were analyzed by both techniques. Urine samples from 19 patients with muscle-invasive tumors and from 19 healthy control subjects were also studied. For FISH analysis, labeled probes for chromosomes 3, 7, 9, and 17 were used to assess chromosomal abnormalities indicative of malignancy. We found a significant difference between the overall sensitivity of FISH and cytology in superficial UC detection (70.3 versus 35.1%, respectively; P < 0.0001). This significant difference was maintained when superficial UCs were broken down into low grade (52.8 versus 13.9%, respectively; P < 0.0005) and high grade (86.8 versus 55.3%, respectively; P < 0.0015) tumors. Overall specificity was 100% for cytology and 94.7% for FISH (difference not significant). Of patients with suspicious cytology, 69% were positive by FISH. Together, these findings suggest that FISH assay for chromosomes 3, 7, 9, and 17 has a higher sensitivity than cytology and a similar specificity in the detection of superficial UC--which could be useful for reducing some cystoscopies in the accurate follow-up usually performed in these patients.


Assuntos
Hibridização in Situ Fluorescente/métodos , Neoplasias da Bexiga Urinária/diagnóstico , Idoso , Citodiagnóstico/métodos , Feminino , Humanos , Masculino , Sensibilidade e Especificidade , Neoplasias da Bexiga Urinária/genética , Neoplasias da Bexiga Urinária/urina
20.
Arch Ital Urol Androl ; 78(4): 130-4, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17269615

RESUMO

Adhesion molecule disorders may be important in different cell control pathways, and consequently in neoplastic cell disorders. This paper will consider only some of the aspects of intercellular relationship. The main anchoring molecule of these two structures is E-cadherin, which is bound to a molecule complex (catenins and vinculin) that connects it to the actin of the cytoplasmatic cytoskeleton. This adhesion molecule complex maintains cell adhesion but it is also involved in differentiation phenomena and may be pathways of action of different growth factors. When we study the expression of E-cadherin according to the Gleason pattern, we verify progressive loss of the adhesion molecule as the Gleason grade increases (abnormal in 35% of Gleason < 7 score versus 75% in cases of Gleason > 7 score). This correlation reinforces the idea of using the expression of adhesion molecules as a prognostic factor. Considering the great interrelation between the various cell-cycle regulating systems, it is probable that an approach to this interweaving through regulation and de-regulation of the adhesion molecule expression may turn out to be one of the most useful pathways in the future.


Assuntos
Caderinas/biossíntese , Neoplasias da Próstata/metabolismo , Neoplasias da Próstata/patologia , Biomarcadores/análise , Caderinas/análise , Humanos , Masculino , Análise em Microsséries , Prognóstico , Prostatectomia , Neoplasias da Próstata/química , Neoplasias da Próstata/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...